Northwest Biotherapeutics INC
SEC CIK 1072379 · NWBT · last insider filing 2024-09-03
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Boynton Alton L | Director · President and CEO | filed 2006 - 2024 |
| Malik Navid | Director | filed 2015 - 2024 |
| Jasinowski Jerry J | Director | filed 2015 - 2022 |
| Powers Linda F | Director · See Remarks | filed 2006 - 2020 |
| Black Cofer | Director | filed 2016 - 2018 |
| Bayh Susan B | Director | filed 2016 - 2016 |
| Farmer Robert A | Director | filed 2015 - 2015 |
| Harris Steve | Director | filed 2007 - 2007 |
| Deasey Anthony P | Director · Senior VP of Finance - CFO | filed 2007 - 2007 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Bosch Marnix L | Chief Technical Officer | filed 2017 - 2024 |
| Goldman Leslie J. | Senior Vice President | filed 2018 - 2020 |
| Davis Jean M. | See Remarks | filed 2019 - 2019 |
| Johnston JIM D | CFO & Gen Counsel | filed 2007 - 2007 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.